Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
341.6M
Cash
137M
Avg Qtr Burn
-18.42M
Short % of Float
6.75%
Insider Ownership
6.44%
Institutional Own.
91.38%
Qtr Updated
09/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
KRRO-110 Details Alpha-1 Antitrypsin Deficiency | Phase 1/2 Data readout | |
FX-322 Details Ear disease, Sensorineural hearing loss | Failed Discontinued | |
FX-345 Details Sensorineural hearing loss, Ear disease | Failed Discontinued |